axsome.com
US medical affairs
This website is intended for US healthcare professionals only.

congress
presentations

AMCP Nexus 2024

Las Vegas, NV
October 14-17, 2024

PDF screenshot

AXS-05 | Major Depressive Disorder

Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder
view/download
 

AXS-05 | Major Depressive Disorder

Dr. Andrew Muzyk, PharmD describes the “Real-World Auvelity® (AXS-05) Patient Characteristics in Major Depressive Disorder” Poster
view
PDF screenshot

AXS-05 | Major Depressive Disorder

Auvelity® (AXS-05) in Major Depressive Disorder: Pooled Data from Two Six-Week Controlled Trials (GEMINI and ASCEND)
view/download
PDF screenshot

AXS-05 | Alzheimer’s Disease Agitation

Clinical Profile of AXS-05 (Dextromethorphan-Bupropion) in Treating Alzheimer’s Disease Agitation: Results From The Phase 2/3 Development Program
view/download
 

AXS-05 | Alzheimer’s Disease Agitation

Dr. Jeffrey L. Cummings, MD, ScD describes the “Clinical Profile of AXS-05 (Dextromethorphan-Bupropion) in Treating Alzheimer’s Disease Agitation: Results From The Phase 2/3 Development Program” Poster
view
PDF screenshot

AXS-07 | Migraine

Combined Efficacy and Safety of AXS-07 (MoSEICTM Meloxicam and Rizatriptan) in Two Phase 3 Clinical Trials
view/download

This site is intended for registered attendees of the respective Congress.
This site contains scientific presentations on investigational products and/or investigational uses of approved products for Axsome or its partners sponsored studies.
The safety and efficacy of investigational products and/or investigational uses of approved products has not been established and such investigational products/uses have not and may not be approved for marketing by any health authority.
Marketing authorization, approval status, and prescribing information for approved products varies by country. Please seek further details from the health authority in your country such as approved product labeling.

AXSOME and its logos are trademarks or registered trademarks of Axsome Therapeutics, Inc. or its affiliates. Other trademarks are property of their respective owners.

© 2023 Axsome Therapeutics, Inc. All rights reserved. One World Trade Center, 22nd Floor, New York, NY 10007 info@axsome.com